Abeona Therapeutics Inc. (ABEO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Abeona Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.55
+2.25% today
Market cap
$254M
Overall quality
54/100
Kronos AI 30-day
+25.1%
8 of 8 simulated paths end higher
Abeona Therapeutics Inc. (ABEO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $254M. It trades at $4.55, up 2.25% today. Its overall quality score is 54 out of 100, ranked against the whole US market. 3 analysts' average target of $22.00 implies +383.5% from today's price. Kronos AI's 30-day forecast is +25.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.00 |
| Low – high | $17.00 – $30.00 |
| Analysts | 3 |
| Upside to average | +383.5% |
Kronos AI 30-day forecast
| Expected close | $5.56 (+25.1%) |
| Likely range | +19.7% … +33.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 12 |
| Solvency | 54 |
| Growth | 97 |
| Overall | 54 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.